维普期刊资源整合服务平台（V6.5）

34篇 您的检索式：作者名="Gaiger"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Use of Protein Chip array surface enhanced laser desorption/ionization time-offlight mass spectrometry (SELDI-TOF MS) to identify thymosin beta-4, a differentially secreted protein from lymphoblastoid cell lines显示文摘	Diamond DL Zhang Y Gaiger A	2003	Journal of the American Society for Mass Spectrometry2003，14，7：	1
2	Increase of bcr-abl chimeric mRNA expression in tumor cells of patients with chronic myeloid leukemia precedes disease progression显示文摘	Gaiger A Henn T C eissler K	1995	Blood1995，1586，6：	1
3	Charaeterization of a lymphocyte subset displaying a unique regulatory activity in human deeidua 显示文摘	Amsalem H Gaiger A Mizrahi S	2008	Int Immunol2008，20，9：	1
4	WTI in acute leukemia, chronic myelogenous leukemia and myelodysplastic syndrome: therapeutic potential of WTI targeted therapies显示文摘	ROSENFELD C CHEEVER M A GAIGER A	2003	Leukemia2003，17，7：	1
5	Increase of bcr-abl chimeric mRNA expression in tumor cells of patients with chronic myeloid leukemia precedes disease progression显示文摘	Gaiger A Henn T Horth E	1995	Blood1995，86，6：	1
6	WT1-specific serum antibodies in patients with leukemia显示文摘	Gaiger A Carter L Greinix H	2001	Clin Cancer Res2001，7，3：	1
7	WT1 in acute leukemia,chronic myelogenous leukemia and myelodysplastic syndrome:therapeutic potential of WT1 targeted therapies显示文摘	Rosenfeld C Chever MA Gaiger A	2003	Leukemia2003，17，7：	1
8	Immunity to WTl in the animal model and in patients with acute myeloid leukemia显示文摘	Gaiger A Reese V Disis ML et 01	2000	Blood2000，96，4：	1
9	Increase of bcr-abl chi- meric mRNA expression in tumor cells of patients with chronic myeloid leukemia precedes disease progression 显示文摘	Gaiger A Henn T H6rth E	1995	Blood1995，86，6：	1
10	Use of ProteinChip array surface enhanced laser desorption/ionization time-of-flight mass spectrometry (SELDI-TOF MS) to identify thymosin beta4, a differentially secreted protein from lymphoblastoid cell lines显示文摘	Diamond DL Zhang Y Gaiger A	2003	J Am Soc Mass Spectrom2003，14，7：	1
11	WT1 in acute leukemia, chronic myelogenous leukemia and myelodysplastic syndrome: therapeutic potential of WT1 targeted therapies 显示文摘	Rosenfeld C Cheever MA Gaiger A	2003	Leukemia2003，17，7：	1
12	Detection of the WT1 transcript by RT -PCR in complete remission has no prognostic relevance in de novo acute myeloid leukemia 显示文摘	Gaiger A Schmid D Heinae G	1998	Leukemia1998，12，：	1
13	ERCC1 expression and survival in small cell lung cancer显示文摘	HENNEMANN M SOSTRUZNIK MH GAIGER AM	2009	J Clin Oncol2009，，19：	1
14	WT1 in acute leukemia,chronic myelogenous leukemia and myelodysplastic syndrome:therapeutic potential of WT1 targeted therapies显示文摘	ROSENFELD C CHEEVER M A GAIGER A	2003	Leukemia2003，17，7：	1
15	WT1 in acute leukemia,chronic myelogenous leukemia and myelodysplastic syndrome:Therapeutic potential of WT1 targeted therapies显示文摘	Rosenfeld C Cheever MA Gaiger A	2003	Leukemia2003，17，7：	1
16	Characterization of alymphocyte subset displaying a unique regulatory activityin human decidua显示文摘	Amsalem H Gaiger A Mizrahi S	2008	Int Immunol2008，20，9：	1
17	Increase of bcr-abl chimeric mRNA expression in tumor cells of patients with chronic myeloid leukemia precedes disease progression 显示文摘	Gaiger A Henn T Horth E	1995	Blood1995，86，：	1
18	Characterization of a lym- phocyte subset displaying a unique regulatory activity in human de- cidua 显示文摘	Amsalem H Gaiger A Mizrahi S	2008	Intlmmunol2008，20，9：	1
19	Use of ProteinChip array surface enhanced laser desorption/ionization time-of-flight mass spectrometry (SELDI-TOF MS) to identify thymosin beta-4,a differentially secreted protein from lymphoblastoid cell lines显示文摘	DIAMOND DL ZHANG Y GAIGER A	2003	J Am Soc Mass Spectrom2003，14，7：	1
20	Immunity to WT1 in the animal model and in patients with acute myeloid leukemia显示文摘	GAIGER A REESE V DISIS M L	2000	Blood2000，96，4：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示